SEC Form 4 · accession 0001209191-18-048495
Dolby Laboratories, Inc. · DLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giles Baker
Officer — SVP, Consumer Entertainment
Period of report
Aug 23, 2018
Accepted (ET)
Aug 27, 2018 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001308547
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Aug 23, 2018 | M | 5,000 | $37.35 | A | 35,594 | D | |
| Class A Common StockF2,F1 | Aug 23, 2018 | S | 5,000 | $70.0006 | D | 30,594 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $37.35 | Aug 23, 2018 | M | 5,000 | D | — | Dec 16, 2023 | Class A Common Stock | 5,000 | 43,160 | D |
Explanation of responses
- F1Shares held following the reported transactions include 30,594 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- F2This transaction was executed in multiple trades at prices ranging from $70.00 to $70.01, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3This option was granted for a total of 71,076 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2013, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
Remarks
**All of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.**